Generac控股 GNRC 深 沪
交易中 02-03 10:32:47 美东时间
176.35
+5.390
+3.15%
华盛通- 最 高176.35
- 今 开171.98
- 成交量 6.69万股
- 最 低 171.98
- 昨 收 170.96
- 总市值 103.49亿
- 52周最高 203.2499
- 市盈率 静 32.72
- 换手率 0.11%
- 52周最低 99.50
- 委 比 98.25%
- 总股本 5868.41万
- 历史最高 524.31
- 量 比 0.60
- 振 幅 2.56%
- 历史最低 9.41
- 每 手 1
- 风险率 24.92%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Generac Announces Fourth Quarter and Full-Year 2025 Earnings Release Date and Conference Call
Generac Holdings Inc. announced plans to release its fourth quarter and full-year 2025 financial results on February 11, 2026, with a conference call at 10:00 a.m. EST. A webcast will be available on Generac’s website under the Investor Relations section. Additionally, a replay will be provided post-webcast. Generac, a total energy solutions company founded in 1959, is a leading provider of energy technology solutions for residential, light comme...
01-28 11:00
Generac (GNRC) Stock Slips As Storm Rally Fades
Generac Holdings Inc (NYSE: GNRC) stock is trading lower Monday morning. The pullback comes as traders potentially lock in profits following a winter storm that has hammered parts of the U.S.
01-27 01:29
Merck added to BofA's best ideas list—see all the names
BofA released its updated US 1 list, its best ideas from Buy-rated U.S.-listed stocks covered by its analysts. Merck (MRK) is the newest addition, while Apple (AAPL) was renewed on the list after the ...
01-22 06:33
美股大行评级 | 存储再获大行看好！花旗、瑞银和美银齐上调西部数据、希捷科技等公司目标价；PNC金融服务获6家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Soleno Therapeutics"买入"评级，目标价从110美元升至120美元；富国银行：维持Soleno Therapeutics"超配"评级，目标价从106美元升至114美元
01-21 11:42
Barclays Maintains Equal-Weight on Generac Hldgs, Lowers Price Target to $186
Barclays analyst Christine Cho maintains Generac Hldgs (NYSE:GNRC) with a Equal-Weight and lowers the price target from $197 to $186.
01-21 00:46
美股大行评级 | 高盛上调谷歌目标价从330美元升至375美元；5家大行集体上调Five Below目标价最高至255美元
今日重点评级关注：HC Wainwright & Co.：维持NioCorp Developments"买入"评级，目标价从9.5美元升至11.25美元；摩根士丹利：维持Chewy"超配"评级，目标价从48美元升至51美元
01-14 11:25
美股大行评级 | Medline获14家大行首予评级，最高目标价52美元；富国银行上调GOOGL目标价从268美元升至350美元
今日重点评级关注：HC Wainwright & Co.：维持Enlivex Therapeutics"买入"评级，目标价从7美元升至13美元；BTIG：维持Oruka Therapeutics"买入"评级，目标价从63美元升至73美元
01-13 10:18
美股大行评级 | 瑞穗上调英伟达、谷歌、美光科技、SanDisk多家科技股目标价；中金首予诺和诺德"跑赢大市"评级，目标价73.5美元
今日重点评级关注：Needham：维持Cartesian Therapeutics"买入"评级，目标价从40美元升至42美元；Piper Sandler：维持Acrivon Therapeutics"超配"评级，目标价从6美元升至8美元
01-12 14:09
美股大行评级 | 潜在涨幅197.4%！奥麦罗制药获HC Wainwright升目标价至40美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持奥麦罗制药"买入"评级，目标价从20美元升至40美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从26美元升至27美元
01-09 20:22
Citigroup Upgrades Generac Hldgs to Buy, Maintains Price Target to $207
Citigroup analyst Vikram Bagri upgrades Generac Hldgs (NYSE:GNRC) from Neutral to Buy and maintains the price target from $207 to $207.
01-09 04:22
